NEW YORK (GenomeWeb) – Precision for Medicine said today that it has acquired Houston-based ApoCell, which specializes in the identification and analysis of biomarkers in both tissue and liquid biopsy.

Specific terms of the deal were not disclosed.

The acquisition adds ApoCell's ApoStream liquid biopsy technology and its expertise in tissue genomic profiling to Precision's existing suite of specialty laboratory and biomarker informatics services, which include cell-based assays and various immune monitoring technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Chinese state news agency Xinhua reports that a preliminary investigation has found He Jiankui performed his gene-editing work illegally.

John Mendelsohn, a former president of the University of Texas MD Anderson Cancer Center, has died, the New York Times reports.

Identical twins receive different estimates of ancestry from the same direct-to-consumer genetic testing firms, CBC reports.

In PNAS this week: chromosomal features of maize, adaptations in the vinous-throated parrotbill, and more.